Clinical trial
Efficacy of Oral Tolerance Induction to Raw Apple Using an Ultra Rush Protocol in 28 Rosacea Allergic Patients
NCT04116580 is registered in ClinicalTrials.gov with Michel Bouvier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Oral Tolerance Induction to Raw Apple Using an Ultra Rush Protocol in 28 Rosacea Allergic Patients
- Lead sponsor
- Michel Bouvier
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2016
- Completion date
- October 31, 2018
- Enrollment
- 28 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
allergic reaction caused by food (disorder), oral allergic syndrome